As metastasis yields its biological secrets, researchers hope to apply findings.
Benowitz
Steve
S
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001859:Bone Neoplasms / Q000517:prevention & control* / Q000556:secondary; D001932:Brain Neoplasms / Q000517:prevention & control* / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D000069448:Denosumab; D015195:Drug Design; D066246:ErbB Receptors / Q000032:analysis; D005260:Female; D006801:Humans; D000077341:Lapatinib; D008297:Male; D051379:Mice; D009362:Neoplasm Metastasis / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology; D011799:Quinazolines / Q000494:pharmacology; D053245:RANK Ligand / Q000037:antagonists & inhibitors / Q000494:pharmacology; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis / Q000187:drug effects; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D000069448:Denosumab; D066246:ErbB Receptors; D000077341:Lapatinib; D011799:Quinazolines; D053245:RANK Ligand; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C508053:ERBB2 protein, human